Connection

Raymond DuBois to Mice

Back to Details
This is a "connection" page, showing publications Raymond DuBois has written about Mice.
Raymond DuBois
Connection Strength
1.218
Mice
  1. The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas. Cancer Prev Res (Phila). 2022 05 03; 15(5):285-296.
    View in: PubMed
    Score: 0.088
  2. Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer. Oncogene. 2021 10; 40(41):5984-5992.
    View in: PubMed
    Score: 0.083
  3. CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. Cancer Res. 2017 07 01; 77(13):3655-3665.
    View in: PubMed
    Score: 0.062
  4. CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models. Invest New Drugs. 2014 Dec; 32(6):1105-1112.
    View in: PubMed
    Score: 0.051
  5. Peroxisome proliferator-activated receptor d promotes colonic inflammation and tumor growth. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):7084-9.
    View in: PubMed
    Score: 0.050
  6. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013 Nov 11; 24(5):631-44.
    View in: PubMed
    Score: 0.049
  7. HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways. Cancer Lett. 2013 Dec 01; 341(2):159-65.
    View in: PubMed
    Score: 0.048
  8. Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat Med. 2012 Jan 22; 18(2):224-6.
    View in: PubMed
    Score: 0.043
  9. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res. 2011 Nov 15; 71(22):7010-20.
    View in: PubMed
    Score: 0.042
  10. Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer. Gastroenterol Clin North Am. 2010 Sep; 39(3):697-707.
    View in: PubMed
    Score: 0.039
  11. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells. Cancer Res. 2010 Jan 15; 70(2):824-31.
    View in: PubMed
    Score: 0.037
  12. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer. Cancer Res. 2008 Nov 15; 68(22):9331-7.
    View in: PubMed
    Score: 0.034
  13. Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res. 2008 Aug 01; 68(15):6468-76.
    View in: PubMed
    Score: 0.034
  14. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett. 2008 Aug 28; 267(2):197-203.
    View in: PubMed
    Score: 0.033
  15. Regulation of prostaglandin transporters in colorectal neoplasia. Cancer Prev Res (Phila). 2008 Jul; 1(2):93-9.
    View in: PubMed
    Score: 0.033
  16. Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res. 2007 Oct 01; 67(19):9380-8.
    View in: PubMed
    Score: 0.032
  17. Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):19069-74.
    View in: PubMed
    Score: 0.030
  18. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. Cancer Res. 2006 Jul 01; 66(13):6649-56.
    View in: PubMed
    Score: 0.029
  19. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006 Apr 17; 203(4):941-51.
    View in: PubMed
    Score: 0.029
  20. Connecting COX-2 and Wnt in cancer. Cancer Cell. 2006 Jan; 9(1):6-8.
    View in: PubMed
    Score: 0.028
  21. Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Dev Biol. 2006 Jan 15; 289(2):263-72.
    View in: PubMed
    Score: 0.028
  22. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006 Feb 03; 281(5):2676-82.
    View in: PubMed
    Score: 0.028
  23. Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2. Gastroenterology. 2005 Aug; 129(2):577-90.
    View in: PubMed
    Score: 0.027
  24. Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Res. 2005 Mar 01; 65(5):1822-9.
    View in: PubMed
    Score: 0.027
  25. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem. 2005 Feb 04; 280(5):3217-23.
    View in: PubMed
    Score: 0.026
  26. Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer. J Biol Chem. 2005 Jan 07; 280(1):476-83.
    View in: PubMed
    Score: 0.026
  27. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell. 2004 Sep; 6(3):285-95.
    View in: PubMed
    Score: 0.026
  28. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat Med. 2004 Mar; 10(3):245-7.
    View in: PubMed
    Score: 0.025
  29. Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):415-6.
    View in: PubMed
    Score: 0.025
  30. Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms. J Biol Chem. 2003 Jun 20; 278(25):22669-77.
    View in: PubMed
    Score: 0.023
  31. Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry. PLoS One. 2013; 8(4):e61379.
    View in: PubMed
    Score: 0.012
  32. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest. 2011 Nov; 121(11):4526-36.
    View in: PubMed
    Score: 0.011
  33. Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor delta signaling is critical to pregnancy success. J Biol Chem. 2007 Dec 28; 282(52):37770-82.
    View in: PubMed
    Score: 0.008
  34. Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res. 2007 Jun 01; 67(11):5285-92.
    View in: PubMed
    Score: 0.008
  35. Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn. 2006 Jun; 235(6):1563-70.
    View in: PubMed
    Score: 0.007
  36. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J Biol Chem. 2005 Oct 21; 280(42):35562-70.
    View in: PubMed
    Score: 0.007
  37. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 2005 May 01; 65(9):3735-44.
    View in: PubMed
    Score: 0.007
  38. Requirement of phospholipase D1 activity in H-RasV12-induced transformation. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1638-42.
    View in: PubMed
    Score: 0.007
  39. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med. 2004 Oct; 10(10):1074-80.
    View in: PubMed
    Score: 0.006
  40. Effects of transforming growth factor-alpha (TGF-alpha) in vitro and in vivo on reovirus replication. DNA Cell Biol. 2004 Jul; 23(7):430-41.
    View in: PubMed
    Score: 0.006
  41. Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J Biol Chem. 2003 Feb 28; 278(9):7683-91.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.